The EPS projection of IBERIABANK Corporation (NASDAQ:IBKC) for period quarter closed 2016-12-31 is $1.2.
The EPS estimates given 30-days and 1 week ago were $1.2 and $1.2, correspondingly. This number 90 and 60 days before was $1.2 and $1.2 respectively. Yet, from last week, the change in EPS prediction is 0%.
For the quarter ended 2 mean estimate is $1.2 based on 8 EPS estimations. As on 2016-07-27 estimated EPS was $1.18 showing surprise of $0.03, or 2.61%. Following the given predictions, the standard deviation is $0.03.
The upgrade count for EPS revisions was 0 a week earlier paralleled to negative revisions of 1. In last 60-days and 1- month, the upgrade in EPS reviews were 0 and 0 correspondingly, though for a quarter and 120-days ago, it was 2 and 2 in that sequence.
The negative reviews of EPS in the last 60-days and 1-month were 1 and 1 in that order. But, a quarter and 120-days ago, this numeral was 5 and 5 correspondingly.
EPS reviews downgrade and upgrade for last 18 days were 3 and 3, correspondingly.
Quarterly Sales Estimates
The mathematical mean of apparent yearly sales of IBERIABANK Corporation (NASDAQ:IBKC) is $236.67 and the median is $238.8. The estimate is stated by 6 analysts for the fiscal 2017.
The highest yearly projection is $245.1 and lowest sales mark is $225.52. This results a standard deviation of $7.555.
Almost 6 have reviewed sales target for better in the past week and 6 have downgraded forecasts. Subject to the stated estimates, the intended change in disclosed target from the past week is 0.282%.
Nearly 6 revised sales predictions for better over the past month and 6 have downgraded forecasts. It suggests an average deviation of 0.282% across given estimates.
Just about 6 have revised sales forecast up over the quarter and 6 have downgraded forecasts, hinting to a deviation of 1.071%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...